Evidence map›Paper›PMID 30822217›Full record

ArticleViral immunology2019

A Novel Role for PDZ-Binding Motif of Influenza A Virus Nonstructural Protein 1 in Regulation of Host Susceptibility to Postinfluenza Bacterial Superinfections.

Kelly Shepardson, Kyle Larson, Hanbyul Cho, Laura Logan Johns, Zeynep Malkoc, Kayla Stanek, Julia Wellhman, Sarah Zaiser, Jaelyn Daggs-Olson, Travis Moodie and 3 more

Open access · greenAbstract read
In one paragraph

Article in Viral immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Kelly Shepardson1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Kyle Larson1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Hanbyul Cho1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Laura Logan Johns1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Zeynep Malkoc1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Kayla Stanek1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Julia Wellhman1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Sarah Zaiser2 Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
Jaelyn Daggs-Olson2 Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
Travis Moodie2 Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
Joshua M Klonoski2 Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
Victor C Huber2 Division of Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota.
Agnieszka Rynda-Apple1 Department of Microbiology and Immunology, Montana State University, Bozeman, Montana.
Montana State University · USUniversity of South Dakota · US

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Jeffrey Good · 2012 to 2026
$60.0M
Wichozani-A Healthy Lifestyle for Rural American Indian Youth through Cultural and Physical Activities: A Community-Based Participatory Research StudyP20GM103443 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI Victor Chester Huber · 2012 to 2026
$58.1M
Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2014 to 2018
$5.4M
Production of therapeutic human polyclonal antibodies against influenza virusesR44AI117976 · NIAID · SAB BIOTHERAPEUTICS, INC. · PI BAUSCH, CHRISTOPH, HUBER, VICTOR CHESTER · 2016 to 2017
$1.4M
Development of novel, safe and efficacious Coxiella burnetii vaccineR21AI119772 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI JUTILA, MARK A, RYNDA-APPLE, AGNIESZKA · 2015 to 2016
$396k
NIAID NIH HHS R21 AI119772NIAID NIH HHS R44 AI117976NIGMS NIH HHS P20 GM103443NIGMS NIH HHS P20 GM103474NIGMS NIH HHS P30 GM110732
6 · The paper itself

Abstract

Influenza A viruses (IAVs) have multiple mechanisms for altering the host immune response to aid in virus survival and propagation. While both type I and II interferons (IFNs) have been associated with increased bacterial superinfection (BSI) susceptibility, we found that in some cases type I IFNs can be beneficial for BSI outcome. Specifically, we have shown that antagonism of the type I IFN response during infection by some IAVs can lead to the development of deadly BSI. The nonstructural protein 1 (NS1) from IAV is well known for manipulating host type I IFN responses, but the viral proteins mediating BSI severity remain unknown. In this study, we demonstrate that the PDZ-binding motif (PDZ-bm) of the NS1 C-terminal region from mouse-adapted A/Puerto Rico/8/34-H1N1 (PR8) IAV dictates BSI susceptibility through regulation of IFN-α/β production. Deletion of the NS1 PDZ-bm from PR8 IAV (PR8-TRUNC) resulted in 100% survival and decreased bacterial burden in superinfected mice compared with 0% survival in mice superinfected after PR8 infection. This reduction in BSI susceptibility after infection with PR8-TRUNC was due to the presence of IFN-β, as protection from BSI was lost in Ifn-β

Indexed as

AnimalsDogsGene Expression RegulationHEK293 CellsHost-Pathogen InteractionsHumansImmunity, InnateInfluenza A Virus, H1N1 SubtypeInfluenza A Virus, H3N2 SubtypeInfluenza, HumanInterferon-betaInterferon Type IMadin Darby Canine Kidney CellsOrthomyxoviridae InfectionsPDZ DomainsSuperinfectionInterferon-betaInterferon Type IViral Nonstructural Proteinsantiviral immunitybacterial superinfectioninfluenzainterferonsNS1

Identifiers

PMID30822217
PMCPMC6479245
OpenAlexW2919177791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.